J Stroke.
2022 May;24(2):288-291. 10.5853/jos.2021.03741.
A Retrospective Study on the Status of Risk Factor Management in Patients with Ischemic Stroke Based on a Large Linked Dataset of Stroke Patients in Korea
- Affiliations
-
- 1Department of Neurology, Seoul National University Hospital, Seoul, Korea
- 2Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Korea
- 3Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 4Department of Critical Care Medicine, Inha University Hospital, Incheon, Korea
- 5Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea
- 6Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu, Korea
- KMID: 2530531
- DOI: http://doi.org/10.5853/jos.2021.03741
Reference
-
References
1. Hong KS, Bang OY, Kim JS, Heo JH, Yu KH, Bae HJ, et al. Stroke statistics in Korea: Part II stroke awareness and acute stroke care, a report from the Korean Stroke Society and Clinical Research Center For Stroke. J Stroke. 2013; 15:67–77.
Article2. Park TH, Ko Y, Lee SJ, Lee KB, Lee J, Han MK, et al. Identifying target risk factors using population attributable risks of ischemic stroke by age and sex. J Stroke. 2015; 17:302–311.
Article3. Bucholz EM, Gooding HC, de Ferranti SD. Awareness of cardiovascular risk factors in U.S. young adults aged 18-39 years. Am J Prev Med. 2018; 54:e67–e77.
Article4. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010; 376:112–123.
Article
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Risk Factors and Biomarkers of Ischemic Stroke in Cancer Patients
- Cerebrovascular Disease : Overview and Classification
- Gender Differences in Risk Factor and Clinical Outcome in Patients with Ischemic Stroke
- Relation of Stroke Risk Factors to Severity and Disability after Ischemic Stroke
- Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack
